hammers22
Posted - 1 day ago
$CABA what’s going on here?
HODLnCaulfield
Posted - 1 day ago
$CABA waiting for re entry here but it can’t seem to find its footing.
buddyopalosam
Posted - 2 days ago
$CABA This just broke support at 16 and next levels are close to 12 and 8.
HODLnCaulfield
Posted - 2 days ago
$CABA This thing can’t seem to find support 🤔
Mulhollandr
Posted - 2 days ago
$CLNN 12.6 million shares traded since closing bell yesterday. The rollercoaster continues. Up 50% to now only 10%. What will happen at open is anyone’s guess. Regardless of swings, Remyelination is nothing to scoff at and is a huge deal. If any of my old $CABA or $BLUE peeps are looking for something to take a swing at this might work. Good luck all!
S_Franconi
Posted - 6 days ago
$IOVA $CABA The legislation is still being debated by Congress and might never become law. Even if enacted, it’s not certain that the legislation’s impact would widen to more companies. But in financial disclosures, companies are sharing the risk, and the stock market is beginning to price it in. https://endpts.com/us-china-tensions-threaten-to-ensnare-additional-chinese-biopharma-contractors/
StockScanners
Posted - 1 week ago
$CABA Keep watch if this holds above 16.50, looking for a bounce
S_Franconi
Posted - 1 week ago
$IOVA $CABA House Foreign Affairs Chair Michael McCaul (R-Texas) and the House Select Committee on China Chair Mike Gallagher (R-Wisc.) — along with Sen. Bill Hagerty (R-Tenn.) https://www.politico.com/news/2023/08/31/raimondo-china-congressional-hawks-00113601
S_Franconi
Posted - 1 week ago
$IOVA $CABA Congress' China hawks seek to add biotech suppliers to Pentagon warning list https://endpts.com/congress-china-hawks-seek-to-add-biotech-suppliers-to-pentagon-warning-list/
S_Franconi
Posted - 1 week ago
$IOVA $CABA Additional drugmakers flag risks of working with WuXi amid heightened US scrutiny https://endpts.com/additional-drugmakers-flag-risks-of-working-with-wuxi-amid-heightened-us-scrutiny/
Chado69
Posted - 2 weeks ago
$CABA thinking of a re entry
monkeyponkey
Posted - 2 weeks ago
$CABA when will CABA pop? The results from the Phase1/2 are expected in H1 24, anyone knows anything more specific?
buddyopalosam
Posted - 2 weeks ago
$CABA support broke. Might go back to 12
YouVSYou
Posted - 03/28/24
$CABA for those that are bored of sh*t
Pennies
YouVSYou
Posted - 03/28/24
$CABA Gorgeous Opportunity here at
The 200MA
DailyStocksPicks
Posted - 03/27/24
My Oversold pick #2 for today is $CABA This company is working on developing targeted cell therapies for autoimmune diseases. With FDA designations advancing its clinical trials and a solid financial strategy aimed at supporting its pipeline, analysts also see significant growth potential despite its current financial losses. $EXAI, $ALLO, $TRML, $HLVX https://youtu.be/7pOcCYEQIxM
Unicorn2020
Posted - 03/27/24
$CABA Bought $16.75 today for a quick swing to $19-20.
DailyStocksPicks
Posted - 03/26/24
Today's Oversold Stock #4: Cabaletta Bio ($CABA): Despite a recent stock price drop and an earnings miss, the company has achieved FDA Orphan Drug Designation for one of its treatments and shows promising progress in clinical trials. This suggests the stock might be oversold, with the market not fully recognizing Cabaletta Bio's potential in the biotech industry. $HLVX, $PRME, $TRML, $ALLO For More Details: https://youtu.be/JXc_UbBbj1o
Unicorn2020
Posted - 03/25/24
$CABA Took some profit @ $18. Will get back around $12.00
Thestocktraderhubzee
Posted - 03/22/24
$CABA adding small size
DailyStocksPicks
Posted - 03/22/24
Today's Oversold Stock #4: Cabaletta Bio ($CABA): Despite a recent stock price drop and an earnings miss, the company has achieved FDA Orphan Drug Designation for one of its treatments and shows promising progress in clinical trials. This suggests the stock might be oversold, with the market not fully recognizing Cabaletta Bio's potential in the biotech industry. $HLVX, $PRME, $TRML, $ALLO For Detailed https://youtu.be/kiXj5yPn9rc
Stocks4thought
Posted - 03/21/24
$CABA Why sell of- ICANS?????????????????
Quantumup
Posted - 03/21/24
Stifel⬆️ $CABA $32 was $31/Buy~believes if CABA-201 looks in-line w/ other CAR T's, invs will gain > comfort around the IASO-procured CAR T's /Co's ability2generate high efficacy data in US pts; thinks CABA's weak because Co hasn't yet Tx'd an SLE pt. Co is clearly making progress in Myositis, and per Stifel's convo w/ Mgmt/r confident that they will have SLE data by 1H24. $grcl $autl $bmy $kytx nvs
Unicorn2020
Posted - 03/21/24
$CABA Added more at the opportunity today @ $16.50. Total average $16.90. Looking for a ride up to $22 soon.
DonCorleone77
Posted - 03/21/24
$CABA Cabaletta Bio reports Q4 EPS (46c), consensus (39c) "Throughout the past year, we set the foundation to enable an efficient development strategy for CABA-201 across a broad range of autoimmune diseases. Clinical sites across the United States are actively recruiting for our myositis and SLE trials, and the first patient has been dosed with no CRS or ICANS of any grade observed as of 21 days following CABA-201 infusion. We look forward to building on this momentum with expansion into additional clinical sites and to delivering data across the RESET program in 2024," said Steven Nichtberger, M.D., Chief Executive Officer and Co-founder of Cabaletta. "By advancing individual, company-sponsored trials for each autoimmune disease without the need for an initial dose escalation study, we believe we have an accelerated path to initiate discussions with the FDA on registrational cohorts and/or studies following treatment of six patients in any one of the nine cohorts...."
Stock_Titan
Posted - 03/21/24
$CABA Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
https://www.stocktitan.net/news/CABA/cabaletta-bio-reports-fourth-quarter-and-full-year-2023-financial-p5qpvlaaylow.html
G101SPM
Posted - 4 weeks ago
@S_Franconi re: $CABA. See how sensitive the tags are -- trades like an active stock. Near term down/midterm up. (1) $CABA $18.05 carries SPM 84.13 tag to suggest neutral stance probably drifting lower to support at $14.50 in near term. (2) $CABA $21.77 ... carries SPM 81.24 tag to $27.00 in midterm. The "tell" is the actual tag value. From our point of view the data is always right. Our issue remains the interruption of the best means to access what the tags are actually saying. There's a level of understanding that we are still learning. For example how does SPM 84.13 (neutral) relate to SPM 81.24 (up), except that SPM 84.13 is a stronger value and therefore more accurate. To date, our interruption of the SPM tag has yielded an accuracy rating near 87%, but the data generated by the algorithm appears to be always right from a hindsight perspective.
G101SPM
Posted - 4 weeks ago
@S_Franconi per request: $CABA $18.05 carries SPM 84.13 tag to suggest neutral stance probably drifting lower to support at $14.50 in near term.
